Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S Wildenhain
P23. Efficient Ex Vivo Lysis of Acute Myeloid Leukaemic (AML) Cells Mediated by Triplebodies With Dual-Targeting Capability in Conjunction With Natural Killer Cells as Effectors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Related publications
Interactions of Human Myeloid Cells With Natural Killer Cell Subsets in Vitro and in Vivo
Journal of Biomedicine and Biotechnology
Targeting Natural Killer Cells to Acute Myeloid Leukemia in Vitro With a CD16 X 33 Bispecific Killer Cell Engager and ADAM17 Inhibition
Clinical Cancer Research
Cancer Research
Oncology
Oncogenicity of Human Papillomavirus- Or Adenovirus-Transformed Cells Correlates With Resistance to Lysis by Natural Killer Cells.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Targeting Cancer Stem Cells With Natural Killer Cell Immunotherapy
Expert Opinion on Biological Therapy
Drug Discovery
Clinical Biochemistry
Pharmacology
Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells by Combining Therapeutic Antibodies With CD20-Specific Immunoligands Engaging NKG2D or NKp30
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Targeting Natural Killer Cells for Tumor Immunotherapy
Frontiers in Immunology
Allergy
Immunology
Discordance Between Transferrin Receptor Expression and Susceptibility to Lysis by Natural Killer Cells.
Journal of Clinical Investigation
Medicine
Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation in Vivo in High-Risk Relapsed Multiple Myeloma Patients
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vδ1+ Γδ T Cells
PLoS ONE
Multidisciplinary
